Keb Asset Management, LLC Bristol Myers Squibb CO Transaction History

Keb Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$68.48 - $81.09 $1,643 - $1,946	-24 Reduced 0.56%	4,300 $309,000
Q3 2022 Oct 27, 2022	BUY	$0.13 - $76.84 $3 - $1,844	24 Added 0.56%	4,324 $307,000
Q2 2022 Aug 09, 2022	BUY	$72.62 - $79.98 $312,266 - $343,914	4,300 New	4,300 $331,000
Q1 2022 May 09, 2022	SELL	$61.48 - $73.72 $279,856 - $335,573	-4,552 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$53.63 - $62.52 $244,123 - $284,591	4,552 New	4,552 $284,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Keb Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Keb Asset Management, LLC with notifications on news.